Catalyst Wire Dossier Catalyst Wire Dossier

Camptosar (irinotecan)

irinotecan · Pfizer
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Camptosar (irinotecan), covering 2012-03-20 to 2014-05-05. Get the full timeline:

Most recent: Clinical Trial Update: Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving Anticonvulsants [Phase 1]

See pricing